EGFR and cancer: Because the above mentioned data demonstrate that GPBAR1 activation causes a EMT and acquisition of a pro-metastatic phenotype, we have the investigated the role in cancer progression of the GPBAR1/EGFR signaling in a murine model of peritoneal carcinomatosis.